In contrast, in a mouse line of Shank3B–/– (SH3 and multiple ankyrin repeat domains 3 deficiency, modeling the Phelan McDermid Syndrome), Tau reduction was not beneficial. This evidence concerns the gene MAPT and Phelan-McDermid syndrome.